Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 15 of 662 for:    SMS

Effect of SMS Reminder and Free Eye Drops on Follow-up Adherence After Trabeculectomy Surgery in Rural China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02328456
Recruitment Status : Completed
First Posted : December 31, 2014
Last Update Posted : April 15, 2016
Sponsor:
Collaborator:
Orbis
Information provided by (Responsible Party):
Congdon Nathan, Sun Yat-sen University

Brief Summary:
The purpose of the study is to use a randomized controlled design to determine the impact of a SMS messaging associated with free eye drops intervention on the following outcomes among patients after trabeculectomy surgery in rural China.

Condition or disease Intervention/treatment Phase
Glaucoma Adherence Other: SMS and free eye drops Not Applicable

Detailed Description:
SMS message reminder is a system which can sent re-visit information to remind the patient about the revisit time and address. The investigators can use the SMS system to find out if it is a useful to reduce the not-attended rate of the revisit appointment among the rural patients.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 209 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: A Randomized Controlled Trail to Determine the Impact of a SMS Reminder Associated With Free Eye Drops on Follow-up Adherence After Trabeculectomy Surgery in Rural China
Study Start Date : December 2014
Actual Primary Completion Date : November 2015
Actual Study Completion Date : November 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma

Arm Intervention/treatment
SMS and free eye drops group
the patient after trabeculectomy surgery in the SMS associated with free eye drops group will receive free eye drops and a SMS reminder message about the revisit time.
Other: SMS and free eye drops
The SMS reminder message will sent to the SMS associated with free eye drops group patients 1 week and 1 day before there appointment to remind them the exact time and address of the revisit appointment.The eye drops will be offered free to the the SMS associated with free eye drops group patients when they revisit on time.

No Intervention: the control group
the patient after trabeculectomy surgery in the control group won't get any free eye drop and reminder message before the appointment.



Primary Outcome Measures :
  1. Not-attended rate [ Time Frame: up to 1 year ]
    Compare the SMS and free eye drops patient not-attend rate with the control group to show the impact of SMS reminder associated with free eye drops on the adherence with scheduled follow-up visit


Secondary Outcome Measures :
  1. Knowledge and Attitudes about glaucoma, glaucoma surgery and importance of follow-up using a questionnaire [ Time Frame: up to 1 year ]
    Using a questionnaire to compare Knowledge and Attitude between the SMS associated with free eye drops group and the control group

  2. Additional factors potentially associated with post-operative follow-up using a patient questionnaire [ Time Frame: up to 1 year ]
    Using a patient questionnaire to compare between the SMS associated with free eye drops group and the control group



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All the patients after trabeculectomy surgery in 4 cooperated rural hospitals

Exclusion Criteria:

  • Both the patient and his/her caretakers don't have cellphone or the one who has cellphone but don't know how to use the SMS function.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02328456


Locations
Layout table for location information
China, Guangdong
Blindness Preventment and Treatment Department
Guangzhou, Guangdong, China, 510060
Sponsors and Collaborators
Congdon Nathan
Orbis
Investigators
Layout table for investigator information
Study Director: Nathan G Congdon, MD,MPH China,Guangdong,Blindness Preventment and Treatment Department,Zhongshan Ophthalmic Center,510060

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Congdon Nathan, vice directior,Blindness Prevention and Treatment Department, Sun Yat-sen University
ClinicalTrials.gov Identifier: NCT02328456     History of Changes
Other Study ID Numbers: ZOC-CREST-COMPLIANCE-GLAUCOMA
First Posted: December 31, 2014    Key Record Dates
Last Update Posted: April 15, 2016
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Glaucoma
Ocular Hypertension
Eye Diseases
Ophthalmic Solutions
Pharmaceutical Solutions